|
CNTX Context Therapeutics Inc 1842952 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-14,558,426.00 |
| Balance Sheet |
|
Current Assets
|
$45,818,862.00 |
|
Assets
|
$46,134,154.00 |
|
Current Liabilities
|
$7,884,579.00 |
|
Liabilities
|
$7,962,103.00 |
|
Equity
|
$38,172,051.00 |
|
Shares Out
|
91879177.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,449,111.00 |
|
Investing Cash Flow
|
$-4,555,746.00 |
| Market Analysis |
Market Cap
|
$47,777,172.04 |
|
Price
|
$0.52 |
|
BVPS
|
0.42 |
|
PB
|
1.24 |
|
EPS
|
-0.15 |
|
FCF
|
$-18,504,857.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:54 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:44 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CNTX documents filed with the SEC.
CNTX Filings
Clear
